Silo Pharma Inc (SILO)

$3.07 0.00 (N/A)
Market Cap 3.85M
Revenue (ttm) 70,000.00
Net Income (ttm) -4.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,042.86%
Debt to Equity Ratio 0.00
Volume 1,693,800
Avg Vol 231,714
Day's Range N/A - N/A
Shares Out 1.25M
Stochastic %K 16%
Beta 0.71
Analysts Strong Sell
Price Target $10.00

Company Profile

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders...

Industry: Biotechnology
Sector: Healthcare
Phone: 718 400 9031
Address:
677 North Washington Boulevard, Sarasota, United States
Rastapasta22
Rastapasta22 Aug. 18 at 9:18 PM
$SILO they just reported shares confirmed the shelf is a resale.
0 · Reply
rayankhader
rayankhader Aug. 18 at 9:04 PM
$SILO new average $2.83 from $3.15
1 · Reply
flychicken1991
flychicken1991 Aug. 18 at 8:57 PM
$SILO Positive (87%): shares can receive upward price support as the patent allowance reduces uncertainty around Canadian intellectual-property protection and increases the perceived strategic value of the PTSD treatment program. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/09dac7785250ea11?utm_source=stocktwits&utm_medium=story_url
0 · Reply
rayankhader
rayankhader Aug. 18 at 8:38 PM
$SILO I bought the dip did you ? 👀
0 · Reply
TheBullsAndBears
TheBullsAndBears Aug. 18 at 8:29 PM
Too my profits from $TNON and moved into $SILO same news ah
0 · Reply
Alienfrom5thDimension
Alienfrom5thDimension Aug. 18 at 8:28 PM
$SILO they're probably selling stock into the news they've done it in the past I believe
0 · Reply
invstdwthaple
invstdwthaple Aug. 18 at 8:27 PM
$SILO Look like bagholders are going to keep this one from running up.
1 · Reply
rayankhader
rayankhader Aug. 18 at 8:26 PM
$SILO removing the sl and let it ride over night Lotto size I’m risking the money 👀
0 · Reply
rayankhader
rayankhader Aug. 18 at 8:22 PM
$SILO lotto size Sl $2.70
0 · Reply
rayankhader
rayankhader Aug. 18 at 8:21 PM
$SILO buying some here now 😴
0 · Reply
Latest News on SILO
Silo Pharma receives notice of allowance from CIPO for PTSD treatment

2026-08-18T20:20:47.000Z - 16 hours ago

Silo Pharma receives notice of allowance from CIPO for PTSD treatment

Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment

Aug 18, 2026, 4:15 PM EDT - 16 hours ago

Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment

Silo Pharma granted European patent covering PTSD therapy

2026-08-10T12:37:05.000Z - 9 days ago

Silo Pharma granted European patent covering PTSD therapy

Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform

Aug 6, 2026, 8:50 AM EDT - 12 days ago

Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform

Silo Pharma files to sell 1.91M shares of common stock for holders

2026-07-24T20:10:24.000Z - 25 days ago

Silo Pharma files to sell 1.91M shares of common stock for holders

Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program

Jul 21, 2026, 8:55 AM EDT - 4 weeks ago

Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program

Silo Pharma subsidiary QwikAgents joins AMD AI program

2026-07-14T13:20:49.000Z - 5 weeks ago

Silo Pharma subsidiary QwikAgents joins AMD AI program

AMD

Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform

Jul 14, 2026, 8:55 AM EDT - 5 weeks ago

Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform

Silo Pharma prices $11.7M at-the-market offering at $6.45 per share

2026-07-10T12:16:17.000Z - 5 weeks ago

Silo Pharma prices $11.7M at-the-market offering at $6.45 per share

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Jul 10, 2026, 8:00 AM EDT - 5 weeks ago

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program

Jul 7, 2026, 8:11 AM EDT - 6 weeks ago

Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program

Silo Pharma engages Resyca to conduct a robustness study for SPC-15 delivery

2026-06-29T20:50:29.000Z - 7 weeks ago

Silo Pharma engages Resyca to conduct a robustness study for SPC-15 delivery

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

Jun 29, 2026, 4:15 PM EDT - 7 weeks ago

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

Silo Pharma reports positive stability data for stress treatment SPC-15

2026-06-23T15:29:15.000Z - 2 months ago

Silo Pharma reports positive stability data for stress treatment SPC-15

Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial

Jun 23, 2026, 8:17 AM EDT - 2 months ago

Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial

Silo Pharma regains compliance with Nasdaq min bid price requirement

2026-06-18T12:33:09.000Z - 2 months ago

Silo Pharma regains compliance with Nasdaq min bid price requirement

Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jun 18, 2026, 8:12 AM EDT - 2 months ago

Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Silo Pharma Inc trading halted, news pending

2026-06-02T23:50:11.000Z - 2 months ago

Silo Pharma Inc trading halted, news pending

Silo Pharma files provisional patent for ibogaine-based therapeutics

2026-05-07T18:37:18.000Z - 3 months ago

Silo Pharma files provisional patent for ibogaine-based therapeutics

Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

May 7, 2026, 8:05 AM EDT - 3 months ago

Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD

Apr 29, 2026, 9:08 AM EDT - 3 months ago

Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD

Silo Pharma expands into AI technology with Qwikagents asset purchase

2026-04-22T21:10:17.000Z - 4 months ago

Silo Pharma expands into AI technology with Qwikagents asset purchase

Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents

Apr 22, 2026, 4:15 PM EDT - 4 months ago

Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents

Silo Pharma gets European Patent Office allowance for PTSD prevention therapy

2026-04-06T20:20:47.000Z - 4 months ago

Silo Pharma gets European Patent Office allowance for PTSD prevention therapy

Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy

Apr 6, 2026, 4:15 PM EDT - 4 months ago

Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy

Silo Pharma announces $1M share repurchase program

2026-02-23T21:38:21.000Z - 6 months ago

Silo Pharma announces $1M share repurchase program

Silo Pharma Announces Share Buyback Program

Feb 23, 2026, 4:15 PM EST - 6 months ago

Silo Pharma Announces Share Buyback Program

Silo Pharma receives Notice of Allowance in Japan for SPC-15

2026-02-18T13:35:47.000Z - 6 months ago

Silo Pharma receives Notice of Allowance in Japan for SPC-15

Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio

Feb 18, 2026, 8:28 AM EST - 6 months ago

Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

Dec 30, 2025, 8:05 AM EST - 8 months ago

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Nov 17, 2025, 8:05 AM EST - 9 months ago

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

Oct 29, 2025, 8:25 AM EDT - 10 months ago

Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Oct 23, 2025, 8:45 AM EDT - 10 months ago

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth

Oct 8, 2025, 8:45 AM EDT - 11 months ago

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth

Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)

Oct 6, 2025, 8:10 AM EDT - 11 months ago

Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Oct 1, 2025, 4:20 PM EDT - 11 months ago

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 30, 2025, 8:02 AM EDT - 11 months ago

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy

Sep 16, 2025, 8:11 AM EDT - 1 year ago

Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

Sep 9, 2025, 9:10 AM EDT - 1 year ago

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

Sep 3, 2025, 8:25 AM EDT - 1 year ago

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

Aug 21, 2025, 2:00 PM EDT - 1 year ago

Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

Aug 19, 2025, 8:05 AM EDT - 1 year ago

Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

Aug 5, 2025, 8:32 AM EDT - 1 year ago

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Jul 16, 2025, 8:45 AM EDT - 1 year ago

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Jul 7, 2025, 8:15 AM EDT - 1 year ago

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Jun 25, 2025, 8:38 AM EDT - 1 year ago

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

Jun 25, 2025, 8:27 AM EDT - 1 year ago

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Jun 11, 2025, 9:00 AM EDT - 1 year ago

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Jun 5, 2025, 9:15 AM EDT - 1 year ago

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 21, 2025, 8:55 AM EDT - 1 year ago

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

Silo Pharma Announces Closing of $2 Million Public Offering

May 16, 2025, 4:15 PM EDT - 1 year ago

Silo Pharma Announces Closing of $2 Million Public Offering

Silo Pharma Announces Pricing of $2 Million Public Offering

May 15, 2025, 9:15 AM EDT - 1 year ago

Silo Pharma Announces Pricing of $2 Million Public Offering

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

May 14, 2025, 4:07 PM EDT - 1 year ago

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

May 14, 2025, 8:40 AM EDT - 1 year ago

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Apr 30, 2025, 8:11 AM EDT - 1 year ago

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Apr 28, 2025, 7:50 AM EDT - 1 year ago

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Mar 26, 2025, 8:40 AM EDT - 1 year ago

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Feb 26, 2025, 1:30 PM EST - 1 year ago

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Feb 18, 2025, 8:50 AM EST - 1 year ago

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Feb 11, 2025, 7:45 AM EST - 1 year ago

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Jan 22, 2025, 8:29 AM EST - 1 year ago

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Jan 2, 2025, 8:45 AM EST - 1 year ago

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Dec 18, 2024, 7:35 AM EST - 1 year ago

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Nov 29, 2024, 8:05 AM EST - 1 year ago

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Rastapasta22
Rastapasta22 Aug. 18 at 9:18 PM
$SILO they just reported shares confirmed the shelf is a resale.
0 · Reply
rayankhader
rayankhader Aug. 18 at 9:04 PM
$SILO new average $2.83 from $3.15
1 · Reply
flychicken1991
flychicken1991 Aug. 18 at 8:57 PM
$SILO Positive (87%): shares can receive upward price support as the patent allowance reduces uncertainty around Canadian intellectual-property protection and increases the perceived strategic value of the PTSD treatment program. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/09dac7785250ea11?utm_source=stocktwits&utm_medium=story_url
0 · Reply
rayankhader
rayankhader Aug. 18 at 8:38 PM
$SILO I bought the dip did you ? 👀
0 · Reply
TheBullsAndBears
TheBullsAndBears Aug. 18 at 8:29 PM
Too my profits from $TNON and moved into $SILO same news ah
0 · Reply
Alienfrom5thDimension
Alienfrom5thDimension Aug. 18 at 8:28 PM
$SILO they're probably selling stock into the news they've done it in the past I believe
0 · Reply
invstdwthaple
invstdwthaple Aug. 18 at 8:27 PM
$SILO Look like bagholders are going to keep this one from running up.
1 · Reply
rayankhader
rayankhader Aug. 18 at 8:26 PM
$SILO removing the sl and let it ride over night Lotto size I’m risking the money 👀
0 · Reply
rayankhader
rayankhader Aug. 18 at 8:22 PM
$SILO lotto size Sl $2.70
0 · Reply
rayankhader
rayankhader Aug. 18 at 8:21 PM
$SILO buying some here now 😴
0 · Reply
doctorslopadopolis
doctorslopadopolis Aug. 18 at 8:18 PM
$SILO wtf is it dropping and going up so fast
0 · Reply
AlertsAndNews
AlertsAndNews Aug. 18 at 8:17 PM
$SILO more patent news, Canada on this one huh Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
0 · Reply
focafoca99
focafoca99 Aug. 17 at 8:22 PM
$SILO increased its authorized common shares to 250 million after shareholder approval.
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 7:47 PM
$BCAB $YAAS $AIFA $SILO $GURE swing
0 · Reply
Adorno99
Adorno99 Aug. 12 at 11:48 AM
$SILO what's going on with this dawg today? Short attack? Don't see any bad news?
0 · Reply
Stock_Catcher
Stock_Catcher Aug. 10 at 12:15 PM
$SILO Silo Pharma Granted European Patent Covering Novel PTSD Therapy
0 · Reply
garygb
garygb Aug. 7 at 7:07 PM
$SILO Short interest declining. Stock is sale priced.
0 · Reply
Adorno99
Adorno99 Aug. 7 at 2:43 PM
$SILO why is SILO tanking today?
0 · Reply
STACKD0E
STACKD0E Aug. 6 at 12:53 PM
$SILO 👁
0 · Reply
Stock_Catcher
Stock_Catcher Aug. 6 at 12:50 PM
$SILO Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
0 · Reply
Joe_90_
Joe_90_ Aug. 4 at 8:49 AM
$SILO good morning folks
0 · Reply